The anti-inflammatory effect of exercise: Its role in diabetes and cardiovascular disease control

Essays in Biochemistry

Volumn 42, Issue , 2006, Pages 105-117

  Pedersen, Bente Klarlund ^a  

^a Centre of Inflammation and Metabolism   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASE; EXERCISE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KINESIOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CYTOKINES; DIABETES MELLITUS, TYPE 2; EXERCISE; EXERCISE THERAPY; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-6; MODELS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247123850     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/bse0420105     Document Type: Article

References (40)

1. Murray, C.J. & Lopez, A.D. (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436-1442
2. Blair, S.N., Cheng, Y. & Holder, J.S. (2001) Is physical activity or physical fitness more important in defining health benefits? Med. Sci. Sports Exercise 33, S379-S399
3. Pedersen, B.K. & Saltin, B. (2006) Evidence for prescribing exercise as therapy in chronic disease. Scand. J. Med. Sci. Sports 16 (Suppl I), 3-63
4. Libby, P. (2002) Inflammation in atherosclerosis. Nature 420, 868-874
5. Dandona, P., Aljada, A. & Bandyopadhyay, A. (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7
6. Ross, R. (1999) Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340, 115-126
7. Festa, A., D'Agostino, Jr, R., Tracy, R.P. & Haffner, S.M. (2002) Elevated levels of acute-phase proteins and plasminogen activator inhibitor-I predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 51, 1131-1137
8. Petersen, A.M. & Pedersen, B.K. (2005) The anti-inflammatory effect of exercise. J. Appl. Physiol. 98, 1154-1162
9. Pedersen, B.K. & Febbraio, M. (2005) Muscle-derived interleukin-6: A possible link between skeletal muscle, adipose tissue, liver, and brain. Brain Behav. Immun. 19, 371-376
10. Pedersen, B.K., Steensberg, A., Fischer, C., Keller, C., Keller, P., Plomgaard, P., Febbraio, M. & Saltin, B. (2003) Searching for the exercise factor: is IL-6 a candidate. J. Muscle Res. Cell Motil. 24, 113-119
11. Pedersen, B.K., Steensberg, A., Fischer, C., Keller, C., Keller, P., Plomgaard, P., Wolsk-Petersen, E. & Febbraio, M. (2004) The metabolic role of IL-6 produced during exercise: is IL-6 an exercise factor? Proc. Nutr. Soc 63, 263-267
12. Taylor, R.S., Brown, A., Ebrahim, S., Jolliffe, J., Noorani, H., Rees, K., Skidmore, B., Stone, J.A., Thompson, D.R. & Oldridge, N. (2004) Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am. J. Med. 116, 682-692
13. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M. et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 344, 1343-1350
14. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A. & Nathan, D.M. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403
15. Boule, N.G., Haddad, E., Kenny, G.P., Wells, G.A. & Sigal, R.J. (2001) Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. J. Am. Med. Assoc 286, 1218-1227
16. UK Prospective Diabetes Study (UKPDS) Group. (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865
17. Coutinho, M., Gerstein, H.C., Wang, Y. & Yusuf, S. (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95783 individuals followed for 12.4 years. Diabetes Care 22, 233-240
18. Bruunsgaard, H. (2005) Physical activity and modulation of systemic low-level inflammation. J. Leukocyte Biol. 78, 819-835
19. Bruunsgaard, H., Andersen-Ranberg, K., Jeune, B., Pedersen, A.N., Skinhoj, P. & Pedersen, B.K. (1999) A high plasma concentration of TNF-α is associated with dementia in centenarians. J. Gerontol. Ser. A 54, M357-M364
20. Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J.R. & Pedersen, B.K. (2005) Tumor necrosis factor-α induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54, 2939-2945
21. Hotamisligil, G.S. (2003) Inflammatory pathways and insulin action. Int J. Obes. Relat Metab. Disord. 27 (Suppl 3), S53-S55
22. Plomgaard, P., Keller, P., Keller, C. & Pedersen, B.K. (2005) TNF-α, but not IL-6, stimulates plasminogen activator inhibitor-1 expression in human subcutaneous adipose tissue. J. Appl. Physiol. 98, 2019-2023
23. Febbraio, M.A. & Pedersen, B.K. (2005) Contraction-induced myokine production and release: is skeletal muscle an endocrine organ? Exerc Sport Sci. Rev. 33, 114-119
24. Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S.L., Ohlsson, C. & Jansson, J.O. (2002) Interleukin-6-deficient mice develop mature-onset obesity. Nat. Med. 8, 75-79
25. Carling, D. (2004) The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Blochem. Sci. 29, 18-24
26. Kelly, M., Keller, C., Avilucea, P.R., Keller, P., Luo, Z., Xiang, X., Giralt, M., Hidalgo, J., Saha, A.K. & Pedersen, B.K. (2004) AMPK activity is diminished in tissues of the IL-6 knockout mice: the effect of exercise. Blochem. Biophys. Res. Commun. 320, 449-454
27. Bruce, C.R. & Dyck, D.J. (2004) Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-α. Am. J. Physiol. Endocrinol. Metab. 287, E616-E621
28. Nonogaki, K., Fuller, G.M., Fuentes, N.L., Moser, A.H., Staprans, I., Grunfeld, C. & Feingold, K.R. (1995) Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136, 2143-2149
29. Path, G., Bornstein, S.R., Gurniak, M., Chrousos, G.P., Scherbaum, W.A. & Hauner, H. (2001) Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by β-adrenergic activation and effects of IL-6 on adipocyte function. J. Clin. Endocrinol. Metab. 86, 2281-2288
30. Petersen, E.W., Carey, A.L., Sacchetti, M., Steinberg, G.R., Macaulay, S.L., Febbraio, M.A. & Pedersen, B.K. (2005) IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro: evidence that IL-6 acts independently of lipolytic hormones. Am. J. Physiol. 288, E155-E162
31. Stouthard, J.M., Romijn, J.A., van der P.T., Endert, E., Klein, S., Bakker, P.J., Veenhof, C.H. & Sauerwein, H.P. (1995) Endocrinologic and metabolic effects of interleukin-6 in humans. Am. J. Physiol. 268, E813-E819
32. Van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Moller, K., Saltin, B., Febbraio, M.A. & Pedersen, B.K. (2003) Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88, 3005-3010
33. Akira, S., Taga, T. & Kishimoto, T. (1993) Interleukin-6 in biology and medicine. Adv. Immunol. 54, 1-78
34. Febbraio, M.A. & Pedersen, B.K. (2002) Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16, 1335-1347
35. Pedersen, B.K. & Hoffman-Goetz, L (2000) Exercise and the immune system: regulation, integration and adaption. Physiol. Rev. 80, 1055-1081
36. Pedersen, B.K., Steensberg, A. & Schjerling, P. (2001) Muscle-derived interleukin-6: possible biological effects. J. Physiol. (London) 536, 329-337
37. Suzuki, K., Nakaji, S., Yamada, M., Totsuka, M., Sato, K. & Sugawara, K. (2002) Systemic inflammatory response to exhaustive exercise. Cytokine kinetics. Exercise Immun. Rev. 8, 6-48
38. Steensberg, A., Keller, C., Starkie, R.L., Osada, T., Febbraio, M.A. & Pedersen, B.K. (2002) IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283, E1272-E1278
39. Keller, P., Keller, C., Carey, A.L., Jauffred, S., Fischer, C.P., Steensberg, A. & Pedersen, B.K. (2003) Interleukin-6 production by contracting human skeletal muscle: Autocrine regulation by IL-6. Biochem. Biophys. Res. Commun. 319, 550-554
40. Tisi, P.V., Hulse, M., Chulakadabba, A., Gosling, P. & Shearman, C.P. (1997) Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur. J. Vasc Endovasc Surg. 14, 344-350